[144] Microchip Technology Inc SEC Filing

Rhea-AI Filing Summary

Microchip Technology, Inc. (MCHP) Form 144 notifies the SEC of a proposed sale of 7,356 shares of common stock through Merrill in San Francisco, with an aggregate market value of $508,593.84 and an approximate sale date of 08/25/2025 on NASDAQ. The filer acquired 3,053 shares as RSUs from Microchip on 08/15/2025 and indicates payment in cash on that date. The filing also discloses a prior sale on 05/23/2025 of 2,015 shares generating $112,275.80 in gross proceeds. The notice includes the standard certification that the seller is unaware of undisclosed material adverse information.

Positive

• Regulatory compliance: Filing provides clear Rule 144 disclosure including broker, share amounts, acquisition details, and seller certification
• Transparency: Prior sale on 05/23/2025 and acquisition date for RSUs are disclosed, aiding insider-activity tracking

Negative

• Insider sale: Proposed sale of 7,356 shares (aggregate value $508,593.84) could be perceived negatively by some investors
• No 10b5-1 plan date provided: Filing does not indicate a trading-plan adoption date or instruction, so sale timing context is limited

Insights

Securities Analyst

TL;DR Routine insider sale filing disclosing proposed sale of 7,356 shares valued at $508,594 and recent prior sale of 2,015 shares.

This Form 144 is a standard regulatory disclosure required when certain insiders propose to sell restricted or control securities in reliance on Rule 144. The filing lists the broker, proposed sale date, the class of security, and acquisition details showing 3,053 RSU shares acquired 08/15/2025 and paid in cash. The prior sale on 05/23/2025 and the signature representation about material information are clearly stated. From a market-impact perspective, the sizes disclosed are modest in isolation and the filing primarily provides compliance transparency rather than new operational information.

Corporate Governance Expert

TL;DR Disclosure aligns with Rule 144 obligations; shows insider monetization of equity with appropriate certification.

The document demonstrates adherence to Rule 144 disclosure mechanics: it identifies broker details, share amounts, acquisition method (RSU), and payment terms. The representation confirming lack of undisclosed material adverse information is standard and important for governance transparency. There is no indication of a trading plan date or other 10b5-1 specifics in the filing. For governance monitoring, this filing is a routine data point for insider activity tracking.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON STOCK	MERRILL 555 CALIFORNIA ST SAN FRANCISCO CA 94103	7356	508593.84	539679667	08/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON STOCK	08/15/2025	RSU	MICROCHIP TECHNOLOGY, INC.			3053	08/15/2025	CASH

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JAMES ERIC BJORNHOLT 2355 WEST CHANDLER BLVD CHANDLER AZ 85224	MICROCHIP TECHNOLOGY INC	05/23/2025	2015	112275.80

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the MCHP Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 7,356 shares of Microchip common stock via Merrill on 08/25/2025 with an aggregate market value of $508,593.84.

How were the securities being sold acquired according to the filing?

The filing shows 3,053 shares were acquired as RSUs from Microchip Technology, Inc. on 08/15/2025, with payment listed as cash.

Did the filer sell other Microchip shares recently?

Yes; the filing reports a prior sale on 05/23/2025 of 2,015 shares yielding $112,275.80 in gross proceeds.

On which exchange is the proposed sale expected to occur?

The proposed sale is expected to occur on NASDAQ.

Does the filing state there is undisclosed material information?

The signer represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.